Macquarie Group’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History
Bought
Maintained
Sold
Other funds holding PHXM
BBA
BI
NMC
SFM
DG
EDRH
Macquarie Group's PHXM Position: Q1 2018 in Review
Macquarie Group sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q1 2018, closing a stake of 60 shares — an estimated $13K sold.
Macquarie Group first reported a position in PHXM in Q4 2017 and held it in 1 quarter. The position peaked at $13K in Q4 2017. 8 funds tracked by Wall St. Rank hold PHXM as of Q1 2018.
- Macquarie Group reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q1 2018 after selling out during the quarter.
- Macquarie Group sold 60 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q1 2018, an estimated $13K.
- Macquarie Group first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q4 2017 and held it in 1 quarter.
- Macquarie Group's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $13K in Q4 2017.
- 8 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q1 2018.
Based on Macquarie Group's 13F filing for Q1 2018, filed 11 May 2018.